Jeffrey B. Kindler
Founder of Centrexion Therapeutics Corp., Jeffrey B. Kindler is a businessperson who has been the head of 8 different companies and holds the position of Chairman at GLG Healthcare Institute, Chief Executive Officer & Director at Centrexion Therapeutics Corp., Venture Partner at Lux Capital Group LLC and Chairman at vTv Therapeutics LLC. Mr. Kindler is also Director at Starboard Capital Partners LLC, Member of The U.S.-Japan Business Council, Inc., Principal at Paragon Pharmaceuticals Capital LLC and Principal at Marathon Pharmaceuticals LLC and on the board of 14 other companies.
In the past Mr. Kindler held the position of Chairman & Chief Executive Officer at Pfizer Inc., Chairman at vTv Therapeutics, Inc., Partner at Williams & Connolly LLP, Trustee at The Business Roundtable, Trustee at The Business Council, Editor at The Harvard Law Review Association, Executive VP-Corporate Relations & General Counsel at McDonald's Corp. and President at Partner Brands (a subsidiary of McDonald's Corp.), Vice President-Litigation & Legal Policy at General Electric Co., Chairman of Boston Market Corp., Chairman for Pharmaceutical Research & Manufacturers of America, Trustee at Ronald McDonald House Charities, Inc., Director at Lincoln Center for the Performing Arts, Inc. and Director at Manhattan Theatre Club, Inc.
He received an undergraduate degree from Tufts University and a graduate degree from Harvard Law School.
|05/07/2021||2,786||Derivative/Non-derivative trans. at $42.96 per share.||119,687|
|05/07/2021||5,804||Derivative/Non-derivative trans. at $42.96 per share.||249,339|
|05/15/2020||2,906||Derivative/Non-derivative trans. at $52.76 per share.||153,321|
|05/15/2020||6,054||Derivative/Non-derivative trans. at $52.76 per share.||319,409|
|05/15/2019||1,907||Derivative/Non-derivative trans. at $49.55 per share.||94,492|
|05/15/2019||3,971||Derivative/Non-derivative trans. at $49.55 per share.||196,763|
|06/06/2018||2,048||Derivative/Non-derivative trans. at $73.22 per share.||149,955|
|06/06/2018||4,265||Derivative/Non-derivative trans. at $73.22 per share.||312,283|
|07/20/2017||489||Derivative/Non-derivative trans. at $75.51 per share.||36,925|
|07/20/2017||1,017||Derivative/Non-derivative trans. at $75.51 per share.||76,793|